Mark Kozloff to Academic Medical Centers
This is a "connection" page, showing publications Mark Kozloff has written about Academic Medical Centers.
Connection Strength
0.034
-
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. Cancer. 2019 05 15; 125(10):1629-1636.
Score: 0.034